Greater China News
China’s CanSino in mRNA vaccine deal with AstraZeneca
CanSino Biologics (6185.HK) has agreed with AstraZeneca (AZN.L) to provide "contract development and manufacturing services" to support the Anglo-Swedish drugmaker's messenger RNA (mRNA) vaccine programme, the Chinese company said on Tuesday.
Hong Kong removes requirement to flag China risk in listing applications
Hong Kong stock exchange has removed a China-risk section for mainland-incorporated companies in its listing application rules with effect from Tuesday, which the bourse said was to align disclosure requirements for IPO-aspirants from other countries and the scrutiny level remains the same.
Biden order proposes new restrictions on China tech investment
President Biden signed an executive order Wednesday aimed at curbing the flow of U.S. investment and management know-how into a limited range of Chinese firms that the administration fears could fuel Beijing’s military ambitions.
China’s medical exports tumble as world moves on from COVID
China's medical exports fell 26.1% year-on-year in the first half of 2023, dragged down by weaker demand amid a sluggish global economic recovery and a high base for comparison.
Baird Medical Submits Disposable Microwave Ablation Needle and MWA System Application to U.S. FDA for Treatment of Soft Tissue Microwave Ablation
Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China, today announced the 510(k) premarket notification submission of the Company's Disposable Microwave Ablation ("MWA") Needle and the Company's MWA System to the U.S. Food and Drug Administration (FDA) for the treatment of soft tissue microwave ablation.
Lynk Pharmaceuticals Announced Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Atopic Dermatitis
HANGZHOU, China, Aug. 9, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced positive topline data from a Phase II clinical trial of LNK01001 for the treatment of atopic dermatitis.
GenScript Biotech and T-MAXIMUM Biotech Form Strategic Alliance on cGMP sgRNA
PISCATAWAY, N.J. and NANJING, China, Aug. 9, 2023 /PRNewswire/ -- GenScript Biotech, the world's leading life-science research tools and services provider, and T-MAXIMUM Biotech, a biotechnology company pioneering universal cell therapies, have formed a strategic collaboration agreement to enable the development of T-MAXIMUM's development CAR-T cell therapy using GenScript's CRISPR nucleic acid reagents.
Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer’s Disease Treatment ADLARITY® in Multiple Markets Across Asia
BOSTON & TAIPEI, Taiwan--(BUSINESS WIRE)--Corium, LLC (“Corium”), a commercial-stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies, and Lotus Pharmaceutical (1795:TT; “Lotus”), a multinational pharmaceutical company, announced that the companies have entered into an exclusive Collaboration and License Agreement for ADLARITY® (donepezil transdermal system), an innovative Alzheimer’s dementia treatment, in ten markets across Asia.
Adlai Norty has filed F-1 with the US SEC for the company to be listed in the US in late July
Adlai Nortye, headquartered in Hangzhou, China and with an office in New Jersey, USA, has filed F-1 with the US SEC for the company to be listed in the US in late July. Cantor is the lead underwriter and CLSA is a co-manager
上海打响“医保支持医药创新”第一枪，全国会否跟进？
Shanghai Municipal Medical Insurance Bureau and seven other departments jointly issued policies for Shanghai to further improve the diversified payment mechanism. Shanghai has become the first province to use medical insurance policies to support pharmaceutical innovation.
